Gulf Evaluation of VAlproate (Depakine Chrono) in maNia Study
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To assess the efficacy of Di-valproate in Bipolar I patients suffering from a manic episode
according to DSM IV (APA 1994) over a 12 weeks period of treatment.
To evaluate the clinical safety of Di-valproate.